What's new

EMEA-002572-PIP02-19-M05

EMEA-002572-PIP02-19-M05

Jun 26, 2025 - 09:50
 0
EMEA-002572-PIP02-19-M05
EMEA-002572-PIP02-19-M05
Read More

Tags:

Previous Article

EMEA-003572-PIP01-23

Next Article

Stepwise Screening of Doping Elements for High‐Voltage LiCoO2 via Materials Geno...

Related Posts

Opinion/decision on a Paediatric investigation plan (PIP): Koselugo, Selumetinib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Congenital, familial and genetic disorders, PIP number: P/0134/2024

Opinion/decision on a Paediatric investigation plan (PI...

Jun 10, 2025  0

Human medicines European public assessment report (EPAR): Advate, octocog alfa, Date of authorisation: 02/03/2004, Revision: 34, Status: Authorised

Human medicines European public assessment report (EPAR...

May 23, 2025  0

EMEA-000834-PIP01-10-M01

EMEA-000834-PIP01-10-M01

Jun 24, 2025  0